About Us
Overview
Leadership
Scientific Advisory Board
Technology
Overview
Transpo-mAb™
SMAC-Technology™
PNU anthracycline payload
Immune Oncology
Publications
Pipeline
News & Events
News
NBE Therapeutics in the News
Events
Contact
Join Our Team
Home
About Us
Overview
Leadership
Scientific Advisory Board
Technology
Overview
Transpo-mAb™
SMAC-Technology™
PNU anthracycline payload
Immune Oncology
Publications
Pipeline
News & Events
News
NBE Therapeutics in the News
Events
Contact
Join Our Team
News
NBE Therapeutics in the News
Events
News
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Select a year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
November 3 - NBE-Therapeutics raises CHF 20 million in Series B financing
Read more
October 20 - NBE-Therapeutics and Sotio a.s. enter into a collaboration for the development of next-generation ADCs using NBE-Therapeutics ADC development technologies
Read more
May 10 - NBE-Therapeutics had presented at BioEquity Conference Europe
Read more
January 5 - NBE-Therapeutics receives CHF 1.1 mio grant for collaboration with Zurich School for Applied Sciences
Read more